Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06132529 · ClinicalTrials.gov registry record
A Study to Evaluate Biomarker Signature to Predict the Persistence of Post-traumatic Headache
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 151
- Enrollment target
NCT06132529: Completed study, sponsored by Mayo Clinic.
NCT06132529 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 151 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06132529 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 151 participants
- Enrollment target
Study Summary
The purpose of this research study is to develop a model to help distinguish patients at high-risk for developing persistent post-traumatic headache from patients who experience headache recovery. Researchers will do this by comparing the brain images, clinical data, and speech of healthy controls to people who have been diagnosed with post-traumatic headache.
Interventions
- DIAGNOSTIC_TEST Brain Magnetic Resonance Imaging (MRI) Scan
- OTHER Speech Sample
- OTHER Electronic Daily Headache Diary
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 151 participants |
| Start Date | 2019-06-03 |
| Est. Completion | 2025-07-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06132529
The ClinicalTrials.gov registry entry for NCT06132529 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 151 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Brain Magnetic Resonance Imaging (MRI) Scan is the first listed.
NCT06132529 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06132529 about?
NCT06132529 is a clinical study titled "A Study to Evaluate Biomarker Signature to Predict the Persistence of Post-traumatic Headache". The purpose of this research study is to develop a model to help distinguish patients at high-risk for developing persistent post-traumatic headache from patients who experience headache recovery. Researchers will do this by comparing the brain images, clinical data, and speech of healthy controls t...
What is the current status of trial NCT06132529?
This trial is currently completed. The enrollment target is 151 participants. The study started on 2019-06-03. Estimated completion is 2025-07-31.
What interventions are being tested in trial NCT06132529?
The interventions under investigation include: Brain Magnetic Resonance Imaging (MRI) Scan (DIAGNOSTIC_TEST), Speech Sample (OTHER), Electronic Daily Headache Diary (OTHER).
Who is sponsoring clinical trial NCT06132529?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.